China's Inflation Data Misses Forecasts as Consumer Prices Slow in March 
Xi Jinping Pushes Demand-Driven Strategy to Modernize China's Service Sector 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 
Gulf Ceasefire Cracks Rattle Asian Markets and Push Oil Prices Higher 
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 
Japan Consumer Confidence Drops Sharply Amid Rising Fuel Costs and Middle East Tensions 
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
Trump Slams Iran Over Strait of Hormuz Oil Restrictions Amid Fragile Ceasefire 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 
Lotte Biologics is reportedly accused of stealing the trade secrets of its rival, Samsung Biologics. A probe into the case was already launched by prosecutors, and officials will be especially checking into some of the company’s employees who were suspected of the crime.
According to The Korea Times, the Incheon District Prosecutors' Office dispatched investigators last week to search the headquarters of Lotte Biologics located in Seoul’s Lotte World Tower. The raid took place on Friday, Oct. 7, and during the search, authorities said they were able to secure the computers of three former workers who were revealed to have moved from Samsung Biologics to Lotte Biologics, but their job positions in the company were not revealed.
Prior to the investigation, it was reported that Samsung Biologics filed to apply for a court directive for the infringement of its company trade secrets in May. In the application for the injunction, it mentioned its three former employees who moved to Lotte Biologics in July.
While their job roles were not disclosed, the three people were said to have work duties related to Samsung Biologics’ core business. The trio was also said to have printed a large number of company documents before transferring to its rival firm, Lotte Biologics.
The Incheon District Court responded to the application by granting Lotte’s request and issuing an injunction against the infringement of trade secrets that were filed by Samsung’s biotechnology business unit on July 29. The directive was to prevent the leak of any business secrets that could be utilized by Lotte Biologics for its benefit.
"We cannot reveal the specifics of the investigation including the search and seizure," the prosecution body commented with regard to the recent raid at the Lotte Biologics HQ
Meanwhile, the biological CDMO (Contract Development Manufacturing Organization) division of the Lotte Group was said to have started hiring bio professionals in the last quarter of 2021 as it was preparing to jump into the bio business. Based on the reports, many of the new hires were recruited from Samsung Biologics.
